Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

NEO214

Product Specifications

CAS Number

1361198-80-2

Target

MTOR, Autophagy

Related Pathways

Autophagy, PI3K/Akt/mTOR signaling

Bioactivity

NEO214, an autophagy inhibitor and a covalent conjugate of the PDE4 inhibitor Rolipram and perillyl alcohol, exhibits anti-cancer activity and blood-brain barrier (BBB) permeability. It prevents autophagy-lysosome fusion, blocking autophagic flux and triggering glioma cell death via mTOR activation and TFEB (Transcription Factor EB) aggregation. NEO214 inhibition of Macroautophagy/autophagy in glioblastoma cells may overcome chemotherapy resistance in glioblastoma [1].

Smiles

C(OCC=1CC[C@H](C(C)=C)CC1)(=O)N2CC(CC2=O)C3=CC(OC4CCCC4)=C(OC)C=C3

Molecular Formula

C27H35NO5

Molecular Weight

453.57

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

GAS2 Antibody (FITC)
orb24261-01 50 µg

GAS2 Antibody (FITC)

Sign In for Pricing
View Details
GAS2 Antibody (FITC)
orb24261-02 100 µg

GAS2 Antibody (FITC)

Sign In for Pricing
View Details
PRRG2 siRNA (Human)
CRH3801-01 15 nmol

PRRG2 siRNA (Human)

Sign In for Pricing
View Details
PRRG2 siRNA (Human)
CRH3801-02 30 nmol

PRRG2 siRNA (Human)

Sign In for Pricing
View Details
4- (4-Methylbenzoyl) piperidine
282691-01 50 mg

4- (4-Methylbenzoyl) piperidine

Sign In for Pricing
View Details
4- (4-Methylbenzoyl) piperidine
282691-02 100 mg

4- (4-Methylbenzoyl) piperidine

Sign In for Pricing
View Details